Ryan, Brent J.

Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease

Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015) · Trends in Biochemical Sciences

Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and Therapy

Cited by 524

Mitochondrial dysfunction and mitophagy in parkinson’s disease: from mechanism to therapy

Malpartida, A. B., Williamson, M., Narendra, D. P., Wade-Martins, R., & Ryan, B. J. (2021) · Trends in Biochemical Sciences

Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and Therapy

Cited by 482

Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model

Janezic, S., Threlfell, S., Dodson, P. D., Dowie, M. J., Taylor, T. N., Potgieter, D., Parkkinen, L., Senior, S. L., Anwar, S., Ryan, B., et al. (2013) · Proceedings of the National Academy of Sciences

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 344

Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases

Ryan, B. J., Nissim, A., & Winyard, P. G. (2014) · Redox Biology

Systemic Lupus Erythematosus ResearchRedox biology and oxidative stress

Cited by 119

Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens

Eggleton, P., Nissim, A., Ryan, B. J., Whiteman, M., & Winyard, P. G. (2013) · Free Radical Biology and Medicine

Systemic Lupus Erythematosus ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 37

Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation

Bogetofte, H., Jensen, P., Okarmus, J., Schmidt, S. I., Agger, M., Ryding, M., Nørregaard, P., Fenger, C., Zeng, X., Graakjær, J., et al. (2019) · Neurobiology of Disease

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 35